In selected cases, short-term reintroduction of low-dose GLP-1 support may be considered as part of a structured long-term strategy rather than continuous treatment
Taking semaglutide injections can improve health markers, including blood work and cholesterol levels
The Le-Vel company background Le-Vel launched in 2012 as a health and wellness direct sales company, quickly building a customer base exceeding 10 million people worldwide
Microdosing advocates claim it can help with weight loss by reducing cravings, better metabolic health, reduce inflammation, enhance mood and cognitive function, and even potentially improve longevity, all while coming with fewer side effects and being more affordable than larger doses
doi: 10.1038/s41392-024-01931-z, Summary Keywords central nervous system, feeding behavior, GLP-1 receptor agonists, gutbrain axis, obesity Citation OConnor RM (2026) Revisiting food addiction in the era of GLP-1based obesity pharmacotherapy via neural reward pathways linking feeding and substance use